vs
Assertio Holdings, Inc.（ASRT）与美国运通（AXP）财务数据对比。点击上方公司名可切换其他公司
美国运通的季度营收约是Assertio Holdings, Inc.的1.4倍（$18.9M vs $13.5M），美国运通同比增速更快（11.4% vs -57.9%），过去两年Assertio Holdings, Inc.的营收复合增速更高（-35.4% vs -95.6%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
美国运通是全球知名的支付服务提供商，主营签账卡、信用卡产品及旅行相关服务，下设全球消费者服务、全球商业服务、全球商户与网络服务三大业务板块，还提供支付融资、网络服务、应付账款费用管理、旅行生活服务等多元解决方案。
ASRT vs AXP — 直观对比
营收规模更大
AXP
是对方的1.4倍
$13.5M
营收增速更快
AXP
高出69.3%
-57.9%
两年增速更快
ASRT
近两年复合增速
-95.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $18.9M |
| 净利润 | — | $3.0M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | — |
| 净利率 | — | 15.7% |
| 营收同比 | -57.9% | 11.4% |
| 净利润同比 | — | 15.0% |
| 每股收益（稀释后） | $-4.54 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTAXP
| Q1 26 | — | $18.9M | ||
| Q4 25 | $13.5M | $10.9B | ||
| Q3 25 | $49.5M | $10.4B | ||
| Q2 25 | $29.2M | $10.3B | ||
| Q1 25 | $26.5M | $9.6B | ||
| Q4 24 | $32.2M | $10.0B | ||
| Q3 24 | $29.2M | $9.7B | ||
| Q2 24 | $31.1M | $9.8B |
净利润ASRTAXP
| Q1 26 | — | $3.0M | ||
| Q4 25 | — | $2.5B | ||
| Q3 25 | $11.4M | $2.9B | ||
| Q2 25 | $-16.4M | $2.9B | ||
| Q1 25 | $-13.5M | $2.6B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | $-2.9M | $2.5B | ||
| Q2 24 | $-3.7M | $3.0B |
营业利润率ASRTAXP
| Q1 26 | — | — | ||
| Q4 25 | -86.7% | 28.2% | ||
| Q3 25 | 23.2% | 36.7% | ||
| Q2 25 | -27.5% | 34.4% | ||
| Q1 25 | -50.0% | 34.6% | ||
| Q4 24 | -41.9% | 27.7% | ||
| Q3 24 | -10.4% | 33.0% | ||
| Q2 24 | -11.6% | 38.6% |
净利率ASRTAXP
| Q1 26 | — | 15.7% | ||
| Q4 25 | — | 22.5% | ||
| Q3 25 | 23.1% | 27.9% | ||
| Q2 25 | -56.0% | 28.0% | ||
| Q1 25 | -51.1% | 26.8% | ||
| Q4 24 | — | 21.8% | ||
| Q3 24 | -10.0% | 25.8% | ||
| Q2 24 | -11.8% | 30.7% |
每股收益（稀释后）ASRTAXP
| Q1 26 | — | — | ||
| Q4 25 | $-4.54 | $3.52 | ||
| Q3 25 | $0.11 | $4.14 | ||
| Q2 25 | $-0.17 | $4.08 | ||
| Q1 25 | $-0.14 | $3.64 | ||
| Q4 24 | $-3.28 | $3.04 | ||
| Q3 24 | $-0.03 | $3.49 | ||
| Q2 24 | $-0.04 | $4.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | — |
| 总债务越低越好 | — | $60.4M |
| 股东权益账面价值 | $94.0M | $34.0M |
| 总资产 | $267.0M | $308.9M |
| 负债/权益比越低杠杆越低 | — | 1.78× |
8季度趋势，按日历期对齐
现金及短期投资ASRTAXP
| Q1 26 | — | — | ||
| Q4 25 | $63.4M | $742.0M | ||
| Q3 25 | $93.4M | $1.3B | ||
| Q2 25 | $98.2M | $197.0M | ||
| Q1 25 | $87.3M | $261.0M | ||
| Q4 24 | $100.1M | $221.0M | ||
| Q3 24 | $88.6M | $120.0M | ||
| Q2 24 | $88.4M | $188.0M |
总债务ASRTAXP
| Q1 26 | — | $60.4M | ||
| Q4 25 | — | $56.4B | ||
| Q3 25 | — | $57.8B | ||
| Q2 25 | — | $58.2B | ||
| Q1 25 | — | $51.2B | ||
| Q4 24 | — | $49.7B | ||
| Q3 24 | — | $53.5B | ||
| Q2 24 | — | $51.5B |
股东权益ASRTAXP
| Q1 26 | — | $34.0M | ||
| Q4 25 | $94.0M | $33.5B | ||
| Q3 25 | $105.8M | $32.4B | ||
| Q2 25 | $93.3M | $32.3B | ||
| Q1 25 | $108.5M | $31.2B | ||
| Q4 24 | $121.1M | $30.3B | ||
| Q3 24 | $130.5M | $29.7B | ||
| Q2 24 | $132.2M | $29.5B |
总资产ASRTAXP
| Q1 26 | — | $308.9M | ||
| Q4 25 | $267.0M | $300.1B | ||
| Q3 25 | $319.8M | $297.6B | ||
| Q2 25 | $273.8M | $295.6B | ||
| Q1 25 | $286.4M | $282.2B | ||
| Q4 24 | $284.7M | $271.5B | ||
| Q3 24 | $276.0M | $271.0B | ||
| Q2 24 | $279.4M | $272.2B |
负债/权益比ASRTAXP
| Q1 26 | — | 1.78× | ||
| Q4 25 | — | 1.68× | ||
| Q3 25 | — | 1.78× | ||
| Q2 25 | — | 1.80× | ||
| Q1 25 | — | 1.64× | ||
| Q4 24 | — | 1.64× | ||
| Q3 24 | — | 1.80× | ||
| Q2 24 | — | 1.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASRTAXP
| Q1 26 | — | — | ||
| Q4 25 | $-30.0M | $3.1B | ||
| Q3 25 | $-4.8M | $6.2B | ||
| Q2 25 | $19.1M | $4.4B | ||
| Q1 25 | $-12.5M | $4.8B | ||
| Q4 24 | $11.5M | $5.8B | ||
| Q3 24 | $-35.0K | $-1.8B | ||
| Q2 24 | $7.4M | $4.5B |
自由现金流ASRTAXP
| Q1 26 | — | — | ||
| Q4 25 | — | $2.3B | ||
| Q3 25 | — | $5.6B | ||
| Q2 25 | — | $3.7B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | — | $-2.3B | ||
| Q2 24 | — | $4.0B |
自由现金流率ASRTAXP
| Q1 26 | — | — | ||
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | — | 45.0% | ||
| Q4 24 | — | 53.1% | ||
| Q3 24 | — | -23.3% | ||
| Q2 24 | — | 40.4% |
资本支出强度ASRTAXP
| Q1 26 | — | — | ||
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 6.3% | ||
| Q2 25 | — | 6.0% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | 0.0% | 4.7% | ||
| Q2 24 | — | 5.8% |
现金转化率ASRTAXP
| Q1 26 | — | — | ||
| Q4 25 | — | 1.25× | ||
| Q3 25 | -0.42× | 2.15× | ||
| Q2 25 | — | 1.51× | ||
| Q1 25 | — | 1.84× | ||
| Q4 24 | — | 2.66× | ||
| Q3 24 | — | -0.72× | ||
| Q2 24 | — | 1.50× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
AXP
| Discount revenue | $9.5M | 50% |
| Other | $8.9M | 47% |
| Deposits with banks and other | $512.0K | 3% |
